EVAX Evaxion A/S
$3.34
Evaxion A/S (EVAX) is confirmed to report earnings on August 20, 2026, before the market open. The stock has had a Post-Earnings Announcement Drift (PEAD) of -23.0% since its last earnings release on May 7, 2026.
Evaxion A/S Reported Earnings
Thursday, May 7, 2026 · 7:30 AM ET
Earnings Date
2nd Quarter, Jun 2026
Aug 20
Thursday · 7:30 AM ET
Earnings Whisper
-
vs -
Rev est $15.83M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$3.56
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Evaxion A/S
Evaxion A/S is a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines. Evaxion A/S, formerly known as Evaxion Biotech A/S, is based in COPENHAGEN, Denmark.
Sector
Healthcare
Industry
Biotechnology